Vehicle Reclamation Services

Jerome Gentolia, Chief Operating Officer of Unilion Oxford Group, is in talks with Vehicle Reclamation Services of Maryland, LLC (VRS) concerning their state-of-the-art vehicle disassembly operations project.

There are over 18 million vehicles a year that have reached the end of their useful life (EOLVs) or are to be scrapped at the traditional, open-air junk yards/shredders.  These numbers will increase in 2009 from the impact of the Cash-for-Clunkers U.S. government program and are estimated to increase to over 20 million for 2010.   VRS provides an indoor, environmentally friendly system that reclaims significanly more reuseable parts than the traditional junk yard would and provides efficient removal of scrap metal while processing a high volume of vehicles in a semi-automated disassembly line.  This is based on a proven Dutch-manufactured system that can be built on a relatively small site.

Starting with one facility, VRS plans to acquire large numbers of EOLVs or scrap vehicles, disassemble the reuseable parts to reclaim them for refurbishment or resale and process the remaining scrap.  One center at full operation has the potential of providing scrap metal that would come from hundreds of junkyards, making it much more convenient and cost-effective for the purchaser.  This one-stop shop also reclaims a much higher percentage of the vehicle’s parts for resale than the traditional junkyard.  They have already begun discussions with several companies to acquire EOLVs and scrap vehicles as well as for purchase agreements for the reclaimed materials and parts.  Initial studies conservatively estimates that the United States alone could support more than 100 centers.

VRS has an experienced management time led by the founder, Mr. Gary R. Sander.  They have already assembled several people with exceptional expertise in their respective fields.  Mr. Sander has been involved in the manufacturing, construction, steel and chemical industries and his team has experience ranging from automotive and plastics industries to plant management and enviromental engineering.

Jerome Gentolia has been keeping a close eye on the project as it has many of the qualities that Unilion Oxford Group is looking for in new projects.  It uses state-of-the-art  technology that also has a proven track record.  It is economically viable and also environmentally friendly.  Lastly, it will be generating income within 12 months.

Jerome Gentolia is the Chief Operating Officer of Unilion Oxford Group and also the Senior Vice President of Unilion Development Group, a private equity firm. He can be reached at jgentolia@uhl-unilion.com.

Medical Technology Company Achieves Breakthough In Organ Preservation and Transportation

The days when human organs used for transplants are stored in plastic bags and placed in Styrofoam containers are numbered. Organ Transport Systems, Inc (OTS) developed a human organ preservation technology that will dramatically improve the quality and increase the availability of vital organs.

Called Life Cradle™, it will drastically elevate a US$ 9 Billion dollar industry by improving the preservation and transportation of human organs by 80% of current US statistics. More so, the cost of Life Cradle ™ is just around 25% of current competing technologies.

As of the present, organs can only be stored up to 4 hours before transplant of which only 35% of organs procured are actually used. OTS Chairman and CEO, Michael B. Holder, stated that post-procurement life of organs can be extended up to 4 times longer with Life Cradle™. Prolonging the storage of organs will dramatically increase the number of lives that can be saved.

The Oxford Group of Unilion Development Group (UDG), a private equity firm, led by Jerome Gentolia, is in talks with OTS to finance the project. Mr. Gentolia, whose wife is a heart transplant coordinator at Montefiore Medical Center, got interested in the project because of his familiarity with the industry and the personalities behind OTS.

According to Gentolia, “Life Cradle™ is a perfect example of what UDG looks for in a project; a focused company, innovative technology and a direct benefit to people around the world…”

The OTS roster boasts of the top men in their respective field. Michael B. Holder, prior to his role in OTS, ran the Technology Solutions business for Premier, Inc, an $18 Billion healthcare company.

The OTS Board of Directors consists of:

·         Tommy G. Thompson, former Secretary of Health and Human Services;

·         Gene A. Pierce, founder of United Network for Organ Sharing (UNOS) and the South East Organ Procurement Foundation;

·         Marvin J. Slepian MD,  Director of Interventional Cardiology and the Director of the Tissue Engineering Laboratory at the University of Arizona Sarver Heart Center

OTS is founded by Hyman P. White, whose international experience includes the complete development of master health care plans for both Malaysia and Indonesia. He currently serves as Executive Vice President of OTS.

Jerome Gentolia is the Chief Operating Officer of Unilion Oxford Group and also the Senior Vice President of Unilion Development Group, a private equity firm. He can be reached at jgentolia@uhl-unilion.com